Latent Toxoplasmosis gondii: Emerging evidence for influences on neuropsychiatric disorders

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 24, Issue 4, 2012, Pages 376-383

  Hurley, Robin A ^a,b,c   Taber, Katherine H ^a,d,e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c Dept of Psychiatry and Behavioral Sciences   (China)

^d Via College of Osteopathic Medicine   (China)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR CHANGE; BLOOD BRAIN BARRIER; BRAIN DISEASE; BRAIN TUMOR; DEGENERATIVE DISEASE; DISEASE TRANSMISSION; ENCEPHALITIS; HUMAN; IMMUNE RESPONSE; MENTAL DEFICIENCY; MENTAL DISEASE; MOOD DISORDER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; PSYCHOSIS; REPRODUCTION; SCHIZOPHRENIA; STRESS; SUICIDE ATTEMPT; TOXOPLASMA GONDII; TOXOPLASMOSIS; TRAFFIC ACCIDENT;

EID: 84871354627     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.12100234     Document Type: Article

References (66)

1. Williams RW: Mapping genes that modulate mouse brain development: a quantitative genetic approach. Results Probl Cell Differ 2000; 21-49
2. Haroon F, Handel U, Angenstein F, et al: Toxoplasma gondii activity inhibits neuronal function in chronically infected mice. PLoS ONE 2012; 7:e35516S
3. Prandovszky E, Gaskell E, Martin H, et al: The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS ONE 2011; 6:e23866
4. Vyas A, Kim SK, Giacomini N, et al: Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors. Proc Natl Acad Sci U S A 2007; 104:6442-6447
5. Melzer TC, Cranston HJ, Weiss LM, et al: Host cell preference of Toxoplasma gondii in murine brain: a confocal study. J Neuroparasitol 2010; 1
6. Berenreiterová M, Flegr J, Kubena AA, et al: The distribution of Toxoplasma gondii cysts in the brain of a mouse with latent toxoplasmosis: implications for the behavioral manipulation hypothesis. PLoS ONE 2011; 6:e28925
7. Afonso C, Paixão VB, Costa RM: Chronic Toxoplasma infection modifies the structure and the risk of host behavior. PLoS ONE 2012; 7:e32489
8. Horacek J, Flegr J, Tintera J, et al: Latent toxoplasmosis reduces gray matter density in schizophrenia but not in controls: voxelbased-morphometry (VBM) study. World J Biol Psychiatry 2012; 13:501-509
9. Innes EA: A brief history and overview of Toxoplasma gondii. Zoonoses Public Health 2010; 57:1-7
10. Sullivan WJ Jr, Jeffers V: Mechanisms of Toxoplasma gondii persistence and latency. FEMS Microbiol Rev 2012; 36:717-733
11. Henriquez SA, Brett R, Alexander J, et al: Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmunomodulation 2009; 16:122-133
12. Jones JL, Dargelas V, Roberts J, et al: Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis 2009; 49:878-884
13. Alvarado-Esquivel C, Alanis-Quiñones OP, Arreola-Valenzuela MA, et al: Seroepidemiology of Toxoplasma gondii infection in psychiatric inpatients in a northern Mexican city. BMC Infect Dis 2006; 6:178
14. Carruthers VB, Suzuki Y: Effects of Toxoplasma gondii infection on the brain. Schizophr Bull 2007; 33:745-751
15. da Silva RC, Langoni H: Toxoplasma gondii: host-parasite interaction and behavior manipulation. Parasitol Res 2009; 105:893-898
16. Yolken RH, Dickerson FB, Fuller Torrey E: Toxoplasma and schizophrenia. Parasite Immunol 2009; 31:706-715
17. Ling VJ, Lester D, Mortensen PB, et al: Toxoplasma gondii seropositivity and suicide rates in women. J Nerv Ment Dis 2011; 199:440-444
18. Flegr J, Stríz I: Potential immunomodulatory effects of latent toxoplasmosis in humans. BMC Infect Dis 2011; 11:274
19. Hutchison WM, Dunachie JF, Siim JC, et al: Life cycle of toxoplasma gondii. BMJ 1969; 4:806
20. Kreuder C, Miller MA, Jessup DA, et al: Patterns of mortality in southern sea otters (Enhydra lutris nereis) from 1998-2001. J Wildl Dis 2003; 39:495-509
21. Hutchison WM, Aitken PP, Wells WP: Chronic Toxoplasma infections and familiarity-novelty discrimination in the mouse. Ann Trop Med Parasitol 1980; 74:145-150
22. Hutchinson WM, Bradley M, Cheyne WM, et al: Behavioural abnormalities in Toxoplasma-infected mice. Ann Trop Med Parasitol 1980; 74:337-345
23. Hutchison WM, Aitken PP, Wells BW: Chronic Toxoplasma infections and motor performance in the mouse. Ann Trop Med Parasitol 1980; 74:507-510
24. Kaushik M, Lamberton PH, Webster JP: The role of parasites and pathogens in influencing generalised anxiety and predation-related fear in the mammalian central nervous system. Horm Behav 2012; 62:191-201 [epub ahead of print]
25. Webster JP: Rats, cats, people, and parasites: the impact of latent toxoplasmosis on behaviour. Microbes Infect 2001; 3:1037-1045
26. Webster JP: The effect of Toxoplasma gondii on animal behavior: playing cat and mouse. Schizophr Bull 2007; 33:752-756
27. Gatkowska J, Wieczorek M, Dziadek B, et al: Behavioral changes in mice caused by Toxoplasma gondii invasion of brain. Parasitol Res 2012; 111:53-58
28. Hermes G, Ajioka JW, Kelly KA, et al: Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. J Neuroinflammation 2008; 5:48
29. Lindová J, Novotná M, Havlícek J, et al: Gender differences in behavioural changes induced by latent toxoplasmosis. Int J Parasitol 2006; 36:1485-1492
30. Flegr J: Effects of toxoplasma on human behavior. Schizophr Bull 2007; 33:757-760
31. Lindová J, Kubena AA, Sturcová H, et al: Pattern of money allocation in experimental games supports the stress hypothesis of gender differences in Toxoplasma gondii-induced behavioural changes. Folia Parasitol (Praha) 2010; 57:136-142
32. Flegr J, Klose J, Novotná M, et al: Increased incidence of traffic accidents in Toxoplasma-infected military drivers and protective effect of RhD molecule revealed by a large-scale prospective cohort study. BMC Infect Dis 2009; 9:72
33. Yereli K, Balcioglu IC, Ozbilgin A: Is Toxoplasma gondii a potential risk for traffic accidents in Turkey? Forensic Sci Int 2006; 163:34-37
34. Kocazeybek B, Oner YA, Turksoy R, et al: Higher prevalence of toxoplasmosis in victims of traffic accidents suggest increased risk of traffic accident in Toxoplasma-infected inhabitants of Istanbul and its suburbs. Forensic Sci Int 2009; 187:103-108
35. Lester D: Brain parasites and suicide. Psychol Rep 2010; 107:424
36. Lester D: Predicting European suicide rates with physiological indices. Psychol Rep 2010; 107:713-714
37. Yagmur F, Yazar S, Temel HO, et al: May Toxoplasma gondii increase suicide attempt: preliminary results in Turkish subjects? Forensic Sci Int 2010; 199:15-17
38. Arling TA, Yolken RH, Lapidus M, et al: Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J Nerv Ment Dis 2009; 197:905-908
39. Okusaga O, Langenberg P, Sleemi A, et al: Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia. Schizophr Res 2011; 133:150-155
40. Zhu S, Guo MF, Feng QC, et al: Epidemiological evidences from China assume that psychiatric-related diseases may be associated with Toxoplasma gondii infection. Neuroendocrinol Lett 2007; 28:115-120
41. Zhu S: Psychosis may be associated with toxoplasmosis. Med Hypotheses 2009; 73:799-801
42. Hinze-Selch D, Däubener W, Erdag S, et al: The diagnosis of a personality disorder increases the likelihood for seropositivity to Toxoplasma gondii in psychiatric patients. Folia Parasitol (Praha) 2010; 57:129-135
43. Torrey EF, Bartko JJ, Lun ZR, et al: Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull 2007; 33:729-736
44. Torrey EF, Bartko JJ, Yolken RH: Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr Bull 2012; 38:642-647
45. Niebuhr DW, Millikan AM, Cowan DN, et al: Selected infectious agents and risk of schizophrenia among U.S. military personnel. Am J Psychiatry 2008; 165:99-106
46. Jones-Brando L, Torrey EF, Yolken R: Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res 2003; 62:237-244
47. Strobl JS, Cassell M, Mitchell SM, et al: Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro. J Parasitol 2007; 93:694-700
48. Goodwin DG, Strobl JS, Lindsay DS: Evaluation of five antischizophrenic agents against Toxoplasma gondii in human cell cultures. J Parasitol 2011; 97:148-151
49. Webster JP, Lamberton PH, Donnelly CA, et al: Parasites as causative agents of human affective disorders? the impact of anti-psychotic, mood-stabilizer, and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour. Proc Biol Sci 2006; 273:1023-1030
50. Goodwin DG, Strobl J, Mitchell SM, et al: Evaluation of the mood-stabilizing agent valproic acid as a preventative for toxoplasmosis in mice and activity against tissue cysts in mice. J Parasitol 2008; 94:555-557
51. Kusbeci OY, Miman O, Yaman M, et al: Could Toxoplasma gondii have any role in Alzheimer disease? Alzheimer Dis Assoc Disord 2011; 25:1-3
52. Jung BK, Pyo KH, Shin KY, et al: Toxoplasma gondii infection in the brain inhibits neuronal degeneration and learning and memory impairments in a murine model of Alzheimer's disease. PLoS ONE 2012; 7:e33312
53. Powell HC, Gibbs CJ Jr, Lorenzo AM, et al: Toxoplasmosis of the central nervous system in the adult: electron microscopic observations. Acta Neuropathol 1978; 41:211-216
54. FalangolaMF, Reichler BS, Petito CK: Histopathology of cerebral toxoplasmosis in human immunodeficiency virus infection: a comparison between patients with early-onset and late-onset acquired immunodeficiency syndrome. Hum Pathol 1994; 25: 1091-1097
55. Lee GT, Antelo F, Mlikotic AA: Best cases from the AFIP: cerebral toxoplasmosis. Radiographics 2009; 29:1200-1205
56. Pusch L, Romeike B, Deckert M, et al: Persistent toxoplasma bradyzoite cysts in the brain: incidental finding in an immunocompetent patient without evidence of a toxoplasmosis. Clin Neuropathol 2009; 28:210-212
57. Ferguson DJ, Hutchison WM: The host-parasite relationship of Toxoplasma gondii in the brains of chronically infected mice. Virchows Arch A Pathol Anat Histopathol 1987; 411:39-43
58. Sims TA, Hay J, Talbot IC: An electron microscope and immunohistochemical study of the intracellular location of Toxoplasma tissue cysts within the brains of mice with congenital toxoplasmosis. Br J Exp Pathol 1989; 70:317-325
59. Stibbs HH: Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii-infected mice. Ann Trop Med Parasitol 1985; 79:153-157
60. Goodwin D, Hrubec TC, Klein BG, et al: Congenital infection of mice with Toxoplasma gondii induces minimal change in behavior and no change in neurotransmitter concentrations. J Parasitol 2012; 98:706-712
61. Gaskell EA, Smith JE, Pinney JW, et al: A unique dual-activity amino acid hydroxylase in Toxoplasma gondii. PLoS ONE 2009; 4:e4801
62. Fuxe K, Dahlström AB, Jonsson G, et al: The discovery of central monoamine neurons gave volume transmission to the wired brain. Prog Neurobiol 2010; 90:82-100
63. House PK, Vyas A, Sapolsky R: Predator cat odors activate sexual arousal pathways in brains of Toxoplasma gondii infected rats. PLoS ONE 2011; 6:e23277
64. Suzuki K, Masuya M, Matsumoto T, et al: High-intensity signals in the basal ganglia from gadolinium-enhanced T1-weighted MRI as an early change in toxoplasma encephalitis in an AIDS patient. J Infect Chemother 2010; 16:135-138
65. KumarGG, MahadevanA, GuruprasadAS, et al: Eccentric target sign in cerebral toxoplasmosis: neuropathological correlate to the imaging feature. J Magn Reson Imaging 2010; 31:1469-1472
66. Wei L, Zhou G, Li Z, et al: Detection of toxoplasmic lesions in mouse brain by USPIO-enhanced magnetic resonance imaging. Magn Reson Imaging 2007; 25:1442-1448